Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Federal Trade Commission
Chinese Patent Office
Farmers Insurance
Covington
Medtronic
Cantor Fitzgerald
McKesson
Cerilliant

Generated: April 22, 2018

DrugPatentWatch Database Preview

DANOCRINE Drug Profile

« Back to Dashboard

Which patents cover Danocrine, and what generic alternatives are available?

Danocrine is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in DANOCRINE is danazol. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the danazol profile page.
Drug patent expirations by year for DANOCRINE
Medical Subject Heading (MeSH) Categories for DANOCRINE
Synonyms for DANOCRINE
(17a)-Pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol
(1R,3aS,3bR,10aR,10bS,12aS)-1-ethynyl-10a,12a-dimethyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-1H-cyclopenta[7,8]phenanthro[3,2-d]isoxazol-1-ol
(1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.0^{2,10}.0^{4,8}.0^{14,18}]icosa-4(8),5,9-trien-17-ol
(1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.0;{2,10}.0;{4,8}.0;{14,18}]icosa-4(8),5,9-trien-17-ol
(1S,2R,13R,14S,17R,18S)-17-ETHYNYL-2,18-DIMETHYL-7-OXA-6-AZAPENTACYCLO[11.7.0.0(2),(1)?.0?,?.0(1)?,(1)?]ICOSA-4(8),5,9-TRIEN-17-OL
[1,2]oxazolo[4',5':2,3]-17alpha-pregn-4-en-20-yn-17-ol
1-Ethynyl-10a,12a-dimethyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-1H-cyclopenta[7,8]phenanthro[3,2-d]isoxazol-1-ol
1-ethynyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-10a,12a-dimethyl-1H-Cyclopenta[7,8]phenanthro[3,2-d]isoxazol-1-ol
17 alpha-pregna-2,4-dien-20-yno[2,3-D] isoxazol-17 beta-ol
17-alpha-2,4-Pregnadien-20-yno(2,3-d)isoxazol-17-ol
17-alpha-Pregn-4-en-20-yno(2,3-d)isoxazol-17-ol
17-alpha-Pregna-2,4-dien-20-yno(2,3-d)isoxazol-17-ol
17.Alpha.-Pregna-2, {4-dien-20-yno[2,3-d]isoxazol-17-ol}
17|A-hydroxy-2,4,17|A-pregnadien-20-yno[2,3-D]isoxazole
17230-88-5
17a-Pregna-2,4-dien-20-yne-[2,3-d]isoxazole-17b-ol
17a-Pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol
17alpha-Pregna-2,4-dien-20-yno(2,3-d)isoxazol-17-ol
17beta-Hydroxy-2,4,17alpha-pregnadien-20-yno[2,3-d]-isoxazole
199957-EP2272825A2
199957-EP2275420A1
1H-Cyclopenta[7,8]phenanthro[3,2-d]isoxazole- pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol deriv.
2,4,17alpha-Pregnadien-20-yno[2,3-d]-isoxa-zol-17-ol
230D885
AC-6836
AC1L1FAD
AC1Q282K
AC1Q29FD
AKOS015961192
Alphapharm Brand of Danazol
AN-9615
anatrol
Antigen Brand of Danazol
API0002209
AS-13035
BDBM50423541
Bonzol
BPBio1_000100
BRD-K48970916-001-03-0
BSPBio_000090
C06938
CAS-17230-88-5
CCG-220105
CCRIS 6747
CHEBI:4315
CHEMBL1479
Chronogyn
CS-4547
Cyclomen
D00289
D09IPV
Danatrol
Danazant
danazol
Danazol (JAN/USP/INN)
Danazol (JP17/USP/INN)
Danazol [USAN:BAN:INN:JAN]
Danazol [USAN:USP:INN:BAN:JAN]
Danazol-ratiopharm
Danazole
Danazolum
Danazolum [INN-Latin]
Danocrine (TN)
Danogen
Danokrin
Danol
Danoval
Danovaol
Danzol
DB01406
DSSTox_CID_2880
DSSTox_GSID_22880
DSSTox_RID_76772
DTXSID2022880
EINECS 241-270-1
ethynyl(dimethyl)[?]ol
GTPL6942
HMS1568E12
HMS2090A22
HMS2095E12
HMS2231M08
HMS3259M10
HY-B1029
Kendrick Brand of Danazol
Ladogal
LS-118524
MCULE-5533294331
MFCD00056838
MLS001066617
MLS001306473
N29QWW3BUO
NC00557
NCGC00164400-01
NCGC00179665-01
NCGC00179665-02
NCGC00179665-04
NCGC00255335-01
Norciden
NSC 270916
NSC270916
Optina
Panacrine
PL000267
Pregna-2, {4-dien-20-yno[2,3-d]isoxazol-17-ol,} (17.alpha.)-
Pregna-2,4-dien-20-yno(2,3-d)isoxazol-17-ol, (17alpha)-
Pregna-2,4-dien-20-yno(2,3-d)isoxazol-17-ol,(17alpha)-
Prestwick_150
Prestwick0_000105
Prestwick1_000105
Prestwick2_000105
Prestwick3_000105
ratiopharm Brand of Danazol
Sanofi Brand of Danazol
Sanofi Synthelabo Brand ofDanazol
Sanofi Winthrop Brand of Danazol
SCHEMBL21107
SMR000058321
SPBio_002029
SR-05000000445
SR-05000000445-2
STOCK1N-23495
Tox21_112114
Tox21_112114_1
Tox21_301940
UNII-N29QWW3BUO
Vasaloc
W-107864
Win 17, 757
WIN 17,757
WIN 17757
Win-17,757
WIN-17757
Winobanin
ZINC3881958

US Patents and Regulatory Information for DANOCRINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us DANOCRINE danazol CAPSULE;ORAL 017557-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us DANOCRINE danazol CAPSULE;ORAL 017557-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us DANOCRINE danazol CAPSULE;ORAL 017557-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Daiichi Sankyo
Cantor Fitzgerald
Deloitte
Boehringer Ingelheim
Teva
Express Scripts
Fish and Richardson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.